Rafael Amado - Insider Trading & Ownership

Entity
Individual
Location
210 East Grand Ave, South San Francisco, California
Summary
The estimated net worth of Rafael Amado is at least $2.59 M dollars as of June 18, 2024. Rafael Amado is the EVP of R&D of Allogene Therapeutics, Inc. and owns shares of Allogene Therapeutics, Inc. (ALLO) stock worth about $1.72 M. Rafael Amado is the President, Head of Global Oncology Research and Development of Zai Lab Ltd and owns shares of Zai Lab Ltd (ZLAB) stock worth about $630 K. Rafael Amado is the Director of Poseida Therapeutics, Inc. and owns shares of Poseida Therapeutics, Inc. (PSTX) stock worth about $243 K.
All Insider Reports
All Insider Reports

Ownership of Rafael Amado

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALLO Allogene Therapeutics, Inc. EVP of R&D $1.72 M Oct 7, 2022
ZLAB Zai Lab Ltd President, Head of Global Oncology Research and Development $630 K -$588 K -48.3% Apr 3, 2024
PSTX Poseida Therapeutics, Inc. Director $243 K Jun 17, 2024

Insider Transactions Reported by Rafael Amado:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership